Literature DB >> 18503577

Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006.

C L Townsend1, M Cortina-Borja, C S Peckham, P A Tookey.   

Abstract

OBJECTIVE: To describe the changing demographic profile of diagnosed HIV-infected pregnant women over time and trends in pregnancy outcome, uptake of interventions and mother-to-child transmission.
DESIGN: National surveillance study.
SETTING: UK and Ireland. POPULATION: Diagnosed HIV-infected pregnant women, 1990-2006.
METHODS: Active surveillance of obstetric and paediatric HIV conducted through the National Study of HIV in Pregnancy and Childhood. MAIN OUTCOME MEASURES: Maternal characteristics, pregnancy outcome, use of antiretroviral therapy, mode of delivery and mother-to-child transmission.
RESULTS: A total of 8327 pregnancies were reported, increasing from 82 in 1990 to 1394 in 2006, with an increasing proportion from areas outside London. Injecting drug use as the reported risk factor for maternal HIV acquisition declined from 49.2% (185/376) in 1990-1993 to 3.1% (125/4009) in 2004-2006 (P < 0.001), while the proportion of women born in sub-Saharan Africa increased from 43.5% (93/214) in 1990-1993 to 78.6% (3076/3912) in 2004-2006 (P < 0.004). Reported pregnancy terminations decreased from 29.6% (111/376) in 1990-1993 to 3.4% (135/4009) in 2004-2006 (P < 0.001). Most (56.4%, 3717/6593) deliveries were by elective caesarean section, with rates highest in 1999 (66.4%, 144/217). Vaginal deliveries increased from 16.6% (36/217) in 1999 to 28.3% (321/1136) in 2006 (P < 0.001). Use of antiretroviral therapy in pregnancy increased over time, reaching 98.4% (1092/1110) in 2006, and the overall mother-to-child transmission rate declined from 18.5% (35/189) in 1990-1993 to 1.0% (29/2832) in 2004-2006.
CONCLUSIONS: The annual number of reported pregnancies increased dramatically between 1990 and 2006, with changing demographic and geographic profiles and substantial changes in pregnancy management and outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18503577     DOI: 10.1111/j.1471-0528.2008.01706.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  30 in total

1.  In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.

Authors:  Raymond Griner; Paige L Williams; Jennifer S Read; George R Seage; Marilyn Crain; Ram Yogev; Rohan Hazra; Kenneth Rich
Journal:  AIDS Patient Care STDS       Date:  2011-06-10       Impact factor: 5.078

Review 2.  Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals.

Authors:  Vitaly A Kushnir; William Lewis
Journal:  Fertil Steril       Date:  2011-06-30       Impact factor: 7.329

3.  Country of Birth of Children With Diagnosed HIV Infection in the United States, 2008-2014.

Authors:  Steven R Nesheim; Laurie Linley; Kristen M Gray; Tianchi Zhang; Jing Shi; Margaret A Lampe; Lauren F FitzHarris
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

Review 4.  HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Authors:  Nisha Andany; Mona R Loutfy
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

Review 5.  Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges.

Authors:  Steven Nesheim; Lauren Fitz Harris; Margaret Lampe
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

Review 6.  Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries.

Authors:  James McIntyre
Journal:  Curr Opin HIV AIDS       Date:  2010-01       Impact factor: 4.283

7.  Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception.

Authors:  Susie E Huntington; Loveleen K Bansi; Claire Thorne; Jane Anderson; Marie-Louise Newell; Graham P Taylor; Deenan Pillay; Teresa Hill; Pat A Tookey; Caroline A Sabin
Journal:  AIDS       Date:  2011-08-24       Impact factor: 4.177

8.  Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.

Authors:  Shema Tariq; Claire L Townsend; Mario Cortina-Borja; Trinh Duong; Jonathan Elford; Claire Thorne; Pat A Tookey
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-01       Impact factor: 3.731

9.  Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.

Authors:  Susie E Huntington; Claire Thorne; Loveleen K Bansi; Jane Anderson; Marie-Louise Newell; Graham P Taylor; Deenan Pillay; Teresa Hill; Pat A Tookey; Caroline A Sabin
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

10.  Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.

Authors:  K Boer; K England; M H Godfried; C Thorne
Journal:  HIV Med       Date:  2010-01-04       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.